Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aytu BioScience Inc (AYTU)
NASDAQ:AYTU
Holding AYTU?
Track your performance easily
Earnings Data
Report Date
Feb 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-$0.28Last Year’s EPS
-$0.04Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 13, 2024
|% Change Since: -20.92%
|Next Earnings Date:Feb 12, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, including the first-ever positive net income and continued positive adjusted EBITDA, along with growth in key product lines and successful cost reduction initiatives. However, there were challenges with an overall decrease in revenue and a decline in gross margins. Despite these challenges, the positive milestones and financial improvements suggest a generally optimistic outlook for the company's future.Company Guidance
During the Aytu BioPharma Q1 2025 earnings call, the company announced several key metrics demonstrating its financial and operational progress. The quarter marked the first time in the company's history that it reported positive net income, alongside its sixth consecutive quarter of positive adjusted EBITDA. The ADHD portfolio showed a sequential net revenue increase of 11% and a year-over-year growth of 1%, bolstered by resolving a rebate dispute that added $3.3 million to the net revenue. The company's pediatric portfolio experienced a 54% sequential revenue growth, signaling a recovery from previous payer-related declines. Additionally, Aytu BioPharma implemented organizational changes expected to reduce operating expenses by at least $2 million annually. The balance sheet remained strong with $20.1 million in cash at the end of September, slightly up from the previous quarter.First Quarter of Positive Net Income
Aytu BioPharma reported positive net income for the first time in the company's history.
Six Consecutive Quarters of Positive Adjusted EBITDA
The company achieved its sixth consecutive quarter of positive adjusted EBITDA.
ADHD Portfolio Growth
ADHD portfolio net revenue was up 11% sequentially and 1% compared to the prior year period.
Pediatric Portfolio Sequential Revenue Growth
Pediatric portfolio saw its first sequential revenue growth in the last 5 quarters, with a 54% increase from the previous quarter.
Cost Reduction Initiatives
Organizational changes are expected to reduce operating expenses by at least $2 million annually.
Strong Balance Sheet
The company has $20.1 million in cash, slightly up from the previous quarter.
Resolution of Rebate Dispute
Resolved a multiyear rebate dispute increasing net revenue by $3.3 million.
---
AYTU Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AYTU Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 13, 2024 | $1.74 | $1.55 | -10.92% |
| Sep 26, 2024 | $2.85 | $2.36 | -17.19% |
| May 15, 2024 | $3.06 | $2.96 | -3.27% |
| Feb 14, 2024 | $3.15 | $3.12 | -0.95% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Aytu BioScience Inc (AYTU) report earnings?
Aytu BioScience Inc (AYTU) is schdueled to report earning on Feb 12, 2025, TBA Not Confirmed.
What is Aytu BioScience Inc (AYTU) earnings time?
Aytu BioScience Inc (AYTU) earnings time is at Feb 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AYTU EPS forecast?
AYTU EPS forecast for the fiscal quarter 2025 (Q2) is -$0.28.
---